Diabetes Drug Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Glucagon-like peptide-1 (GLP-1) agonist, Dipeptidyl-peptidase-4 (DPP-4) inhibitors, Sodium glucose co-transporter 2 (SGLT2) inhibitors, Insulin, Others); Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Impaired Glucose Tolerance, Impaired Fasting Glycaemia)

Report Code: TIPRE00019617 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Diabetes is group of metabolic disorder, often known as diabetes mellitus, marks in high blood glucose levels. Body cells use glucose as a source of energy and insulin is significant for the cells to absorb this glucose. The type 2 diabetes is the most common type and affects over 90% of the global diabetic patients. Diabetes drugs are drugs used by diabetics to maintain the blood glucose levels to restore the blood glucose metabolism to a normal state.

MARKET DYNAMICS

The diabetes drug therapy market is driving due to the rise in geriatric population and increase in prevalence of diabetes worldwide. However, lack of awareness regarding diabetes drug therapy hinders the market's growth. Moreover, rising awareness regarding diabetes care, growing prevalence of obesity are expected to provide opportunities in the global diabetes drug therapy market.

MARKET SCOPE

The "Diabetes Drug Therapy Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of diabetes drug therapy market with detailed market segmentation by product type and application. The diabetes drug therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in diabetes drug therapy market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The diabetes drug therapy market is segmented on the basis of product type and application. Based on product type, the market is segmented as glucagon-like peptide-1 (GLP-1) agonist, Dipeptidyl-peptidase-4 (DPP-4) inhibitors, Sodium glucose co-transporter 2 (SGLT2) inhibitors, Insulin, Others. Based on application, the market is segmented as type 1 diabetes, type 2 diabetes, gestational diabetes, impaired glucose tolerance, impaired fasting glycaemia.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Diabetes drug therapy market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The diabetes drug therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting diabetes drug therapy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Diabetes drug therapy market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the diabetes drug therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Diabetes drug therapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for Diabetes drug therapy in the global market. Below mentioned is the list of few companies engaged in the Diabetes drug therapy market.

The report also includes the profiles of key players in diabetes drug therapy market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Abbott Laboratories
  •   Mannkind Corporation
  •   Bristol Myers Squibb
  •   Medtronic
  •   AstraZeneca
  •   Eli Lilly and Company
  •   GlaxoSmithKline
  •   Sanofi
  •   Novo Nordisk
  •   Novartis International AG

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Diabetes Drug Therapy Market - By Product Type
1.3.2 Diabetes Drug Therapy Market - By Application
1.3.3 Diabetes Drug Therapy Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DIABETES DRUG THERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DIABETES DRUG THERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DIABETES DRUG THERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. DIABETES DRUG THERAPY - GLOBAL MARKET OVERVIEW
6.2. DIABETES DRUG THERAPY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DIABETES DRUG THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONIST
7.3.1. Overview
7.3.2. Glucagon-like peptide-1 (GLP-1) agonist Market Forecast and Analysis
7.4. DIPEPTIDYL-PEPTIDASE-4 (DPP-4) INHIBITORS
7.4.1. Overview
7.4.2. Dipeptidyl-peptidase-4 (DPP-4) inhibitors Market Forecast and Analysis
7.5. SODIUM GLUCOSE CO-TRANSPORTER 2 (SGLT2) INHIBITORS
7.5.1. Overview
7.5.2. Sodium glucose co-transporter 2 (SGLT2) inhibitors Market Forecast and Analysis
7.6. INSULIN
7.6.1. Overview
7.6.2. Insulin Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. DIABETES DRUG THERAPY MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. TYPE 1 DIABETES
8.3.1. Overview
8.3.2. Type 1 Diabetes Market Forecast and Analysis
8.4. TYPE 2 DIABETES
8.4.1. Overview
8.4.2. Type 2 Diabetes Market Forecast and Analysis
8.5. GESTATIONAL DIABETES
8.5.1. Overview
8.5.2. Gestational Diabetes Market Forecast and Analysis
8.6. IMPAIRED GLUCOSE TOLERANCE
8.6.1. Overview
8.6.2. Impaired Glucose Tolerance Market Forecast and Analysis
8.7. IMPAIRED FASTING GLYCAEMIA
8.7.1. Overview
8.7.2. Impaired Fasting Glycaemia Market Forecast and Analysis
9. DIABETES DRUG THERAPY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Diabetes Drug Therapy Market Overview
9.1.2 North America Diabetes Drug Therapy Market Forecasts and Analysis
9.1.3 North America Diabetes Drug Therapy Market Forecasts and Analysis - By Product Type
9.1.4 North America Diabetes Drug Therapy Market Forecasts and Analysis - By Application
9.1.5 North America Diabetes Drug Therapy Market Forecasts and Analysis - By Countries
9.1.5.1 United States Diabetes Drug Therapy Market
9.1.5.1.1 United States Diabetes Drug Therapy Market by Product Type
9.1.5.1.2 United States Diabetes Drug Therapy Market by Application
9.1.5.2 Canada Diabetes Drug Therapy Market
9.1.5.2.1 Canada Diabetes Drug Therapy Market by Product Type
9.1.5.2.2 Canada Diabetes Drug Therapy Market by Application
9.1.5.3 Mexico Diabetes Drug Therapy Market
9.1.5.3.1 Mexico Diabetes Drug Therapy Market by Product Type
9.1.5.3.2 Mexico Diabetes Drug Therapy Market by Application
9.2. EUROPE
9.2.1 Europe Diabetes Drug Therapy Market Overview
9.2.2 Europe Diabetes Drug Therapy Market Forecasts and Analysis
9.2.3 Europe Diabetes Drug Therapy Market Forecasts and Analysis - By Product Type
9.2.4 Europe Diabetes Drug Therapy Market Forecasts and Analysis - By Application
9.2.5 Europe Diabetes Drug Therapy Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Diabetes Drug Therapy Market
9.2.5.1.1 Germany Diabetes Drug Therapy Market by Product Type
9.2.5.1.2 Germany Diabetes Drug Therapy Market by Application
9.2.5.2 France Diabetes Drug Therapy Market
9.2.5.2.1 France Diabetes Drug Therapy Market by Product Type
9.2.5.2.2 France Diabetes Drug Therapy Market by Application
9.2.5.3 Italy Diabetes Drug Therapy Market
9.2.5.3.1 Italy Diabetes Drug Therapy Market by Product Type
9.2.5.3.2 Italy Diabetes Drug Therapy Market by Application
9.2.5.4 Spain Diabetes Drug Therapy Market
9.2.5.4.1 Spain Diabetes Drug Therapy Market by Product Type
9.2.5.4.2 Spain Diabetes Drug Therapy Market by Application
9.2.5.5 United Kingdom Diabetes Drug Therapy Market
9.2.5.5.1 United Kingdom Diabetes Drug Therapy Market by Product Type
9.2.5.5.2 United Kingdom Diabetes Drug Therapy Market by Application
9.2.5.6 Rest of Europe Diabetes Drug Therapy Market
9.2.5.6.1 Rest of Europe Diabetes Drug Therapy Market by Product Type
9.2.5.6.2 Rest of Europe Diabetes Drug Therapy Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Diabetes Drug Therapy Market Overview
9.3.2 Asia-Pacific Diabetes Drug Therapy Market Forecasts and Analysis
9.3.3 Asia-Pacific Diabetes Drug Therapy Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Diabetes Drug Therapy Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Diabetes Drug Therapy Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Diabetes Drug Therapy Market
9.3.5.1.1 Australia Diabetes Drug Therapy Market by Product Type
9.3.5.1.2 Australia Diabetes Drug Therapy Market by Application
9.3.5.2 China Diabetes Drug Therapy Market
9.3.5.2.1 China Diabetes Drug Therapy Market by Product Type
9.3.5.2.2 China Diabetes Drug Therapy Market by Application
9.3.5.3 India Diabetes Drug Therapy Market
9.3.5.3.1 India Diabetes Drug Therapy Market by Product Type
9.3.5.3.2 India Diabetes Drug Therapy Market by Application
9.3.5.4 Japan Diabetes Drug Therapy Market
9.3.5.4.1 Japan Diabetes Drug Therapy Market by Product Type
9.3.5.4.2 Japan Diabetes Drug Therapy Market by Application
9.3.5.5 South Korea Diabetes Drug Therapy Market
9.3.5.5.1 South Korea Diabetes Drug Therapy Market by Product Type
9.3.5.5.2 South Korea Diabetes Drug Therapy Market by Application
9.3.5.6 Rest of Asia-Pacific Diabetes Drug Therapy Market
9.3.5.6.1 Rest of Asia-Pacific Diabetes Drug Therapy Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Diabetes Drug Therapy Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Diabetes Drug Therapy Market Overview
9.4.2 Middle East and Africa Diabetes Drug Therapy Market Forecasts and Analysis
9.4.3 Middle East and Africa Diabetes Drug Therapy Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Diabetes Drug Therapy Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Diabetes Drug Therapy Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Diabetes Drug Therapy Market
9.4.5.1.1 South Africa Diabetes Drug Therapy Market by Product Type
9.4.5.1.2 South Africa Diabetes Drug Therapy Market by Application
9.4.5.2 Saudi Arabia Diabetes Drug Therapy Market
9.4.5.2.1 Saudi Arabia Diabetes Drug Therapy Market by Product Type
9.4.5.2.2 Saudi Arabia Diabetes Drug Therapy Market by Application
9.4.5.3 U.A.E Diabetes Drug Therapy Market
9.4.5.3.1 U.A.E Diabetes Drug Therapy Market by Product Type
9.4.5.3.2 U.A.E Diabetes Drug Therapy Market by Application
9.4.5.4 Rest of Middle East and Africa Diabetes Drug Therapy Market
9.4.5.4.1 Rest of Middle East and Africa Diabetes Drug Therapy Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Diabetes Drug Therapy Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Diabetes Drug Therapy Market Overview
9.5.2 South and Central America Diabetes Drug Therapy Market Forecasts and Analysis
9.5.3 South and Central America Diabetes Drug Therapy Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Diabetes Drug Therapy Market Forecasts and Analysis - By Application
9.5.5 South and Central America Diabetes Drug Therapy Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Diabetes Drug Therapy Market
9.5.5.1.1 Brazil Diabetes Drug Therapy Market by Product Type
9.5.5.1.2 Brazil Diabetes Drug Therapy Market by Application
9.5.5.2 Argentina Diabetes Drug Therapy Market
9.5.5.2.1 Argentina Diabetes Drug Therapy Market by Product Type
9.5.5.2.2 Argentina Diabetes Drug Therapy Market by Application
9.5.5.3 Rest of South and Central America Diabetes Drug Therapy Market
9.5.5.3.1 Rest of South and Central America Diabetes Drug Therapy Market by Product Type
9.5.5.3.2 Rest of South and Central America Diabetes Drug Therapy Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DIABETES DRUG THERAPY MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DIABETES DRUG THERAPY MARKET, KEY COMPANY PROFILES
12.1. ABBOTT LABORATORIES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MANNKIND CORPORATION
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BRISTOL MYERS SQUIBB
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MEDTRONIC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ASTRAZENECA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ELI LILLY AND COMPANY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANOFI
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NOVO NORDISK
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NOVARTIS INTERNATIONAL AG
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. Mannkind Corporation
3. Bristol Myers Squibb
4. Medtronic
5. AstraZeneca
6. Eli Lilly and Company
7. GlaxoSmithKline
8. Sanofi
9. Novo Nordisk
10. Novartis International AG
TIPRE00019617
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking